Description
Trifluoperazineisaphenothiazineantipsychoticthatisclinicallyusedtotreatschizophreniaandanxiety.Trifluoperazinealsoexhibitsanxiolytic,anti-parasitic,anticancer,andanestheticactivities.Thiscompoundinhibitsα1-adrenergicreceptors,calmodulin,andD1/2receptors.InPlasmodium,trifluoperazineinhibitsCa2+-dependentproteinkinase4(CDPK4).Inlungadenocarcinomacells,trifluoperazinedownregulatesexpressionofF-actinandBcl-2,upregulatesexpressionofBaxandphosphorylationofERKandJNK,inducesapoptosis,andinhibitscellularproliferation.Additionally,thiscompoundinhibitsNav1.4/SCNA4andNav1.7/SCN9ANa+channels,causingsensoryandmotorblockadeinvivo.
References
CavagninoA,RossiF,RizziM.Thepotentantiplasmodialcalmodulin-antagoNISTtrifluoperazineinhibitsplasmodiumfalciparumcalcium-dependentproteinkinase4.ProteinPeptLett.2011Dec;18(12):1273-9.PMID:21787279.
ChenQY,WuLJ,WuYQ,etal.MolecularmechanismoftrifluoperazineinducesapoptosisinhumanA549lungadenocarcinomacelllines.MolMedRep.2009Sep-Oct;2(5):811-7.PMID:21475906.
SheetsPL,GernerP,WangCF,etal.InhibitionofNav1.7andNav1.4sodiumchannelsbytrifluoperazineinvolvesthelocalanestheticreceptor.JNeurophysiol.2006Oct;96(4):1848-59.PMID:16807347.
CreeseI,BurtDR,SnyderSH.Dopaminereceptorbindingpredictsclinicalandpharmacologicalpotenciesofantischizophrenicdrugs.JNeuropsychiatryClinNeurosci.1996Spring;8(2):223-6.PMID:9081563.
Huerta-BahenaJ,Villalobos-MolinaR,García-SáinzJA.Trifluoperazineandchlorpromazineantagonizealpha1-butnotalpha2-adrenergiceffects.MolPharmacol.1983Jan;23(1):67-70.PMID:6135146.
YanoT,Kassovska-BratinovaS,TehJS,etal.Reductionofclofaziminebymycobacterialtype2NADH:quinoneoxidoreductase:apathwayforthegenerationofbactericidallevelsofreactiveoxygenspecies.JBiolChem.2011Mar25;286(12):10276-10287.PMID:21193400.